G
Geerard L. Beets
Researcher at Netherlands Cancer Institute
Publications - 311
Citations - 18117
Geerard L. Beets is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Colorectal cancer & Medicine. The author has an hindex of 61, co-authored 270 publications receiving 14472 citations. Previous affiliations of Geerard L. Beets include Tibotec & Champalimaud Foundation.
Papers
More filters
Journal ArticleDOI
Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
Britt J. P. Hupkens,Milou H. Martens,Jan H Stoot,Maaike Berbee,Jarno Melenhorst,Regina G. H. Beets-Tan,Geerard L. Beets,Stephanie O. Breukink +7 more
TL;DR: After a successful watch-and-wait approach, the quality of life was better than after chemoradiation and surgery on several domains, but one-third of the watch- and-wait patients experienced major low anterior resection syndrome symptoms, compared with 66.7% of the patients in the total mesorectal excision group.
Journal ArticleDOI
Open or laparoscopic preperitoneal mesh repair for recurrent inguinal hernia? A randomized controlled trial.
Geerard L. Beets,Carmen D. Dirksen,P. M. N. Y. H. Go,F. E. A. Geisler,Cor G. M. I. Baeten,Gauke Kootstra +5 more
TL;DR: Laroscopic repair of recurrent inguinal hernia has a lower morbidity than GPRVS, but the potential technical failure rate is higher, and the open preperitoneal prosthetic mesh repair remains the best repair.
Journal ArticleDOI
Degradation of mesh coatings and intraperitoneal adhesion formation in an experimental model.
Marc H. F. Schreinemacher,Pieter J. Emans,Marion J.J. Gijbels,Jan Greve,Geerard L. Beets,Nicole D. Bouvy +5 more
TL;DR: The ability of different coated and uncoated meshes to attenuate adhesion formation was examined in laparoscopic ventral hernia repair.
Journal ArticleDOI
Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study
Rutger C.H. Stijns,Eelco J. R. de Graaf,Cornelis J. A. Punt,Iris D. Nagtegaal,Joost J. Nuyttens,Esther van Meerten,Pieter J. Tanis,Ignace H. J. T. de Hingh,George P. van der Schelling,Yair Acherman,Jeroen W. A. Leijtens,Andreas J A Bremers,Geerard L. Beets,Christiaan Hoff,Cornelis Verhoef,Corrie A.M. Marijnen,Johannes H. W. de Wilt +16 more
TL;DR: In early-stage rectal cancer (cT1-3N0M0), CRT enables organ preservation with additional TEM surgery in approximately two-thirds of patients with good long-term oncological outcome and HRQL, and this multimodality treatment triggers a certain degree of bowel dysfunction.
Journal ArticleDOI
Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial
Marcel den Dulk,Corrie A.M. Marijnen,Hein Putter,Harm J. T. Rutten,Geerard L. Beets,Theo Wiggers,Iris D. Nagtegaal,Cornelis J.H. van de Velde +7 more
TL;DR: Age, T-Stage, N-stage, CRM, distance of the tumor to the anal verge, and tumor location were independent risk factors for adverse outcome in patients treated with an APR for low rectal cancer.